当前位置: X-MOL 学术Eur. Respir. J. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
COVID-19 follow-up programmes across Europe: an ERS END-COVID CRC survey
European Respiratory Journal ( IF 16.6 ) Pub Date : 2022-09-15 , DOI: 10.1183/13993003.00923-2022
Claudia Valenzuela 1 , Mattia Nigro 2 , James D Chalmers 3 , Scott Wagers 4 , Aujayeb Avinash 5 , Merel E Hellemons 6 , Judith Löffler-Ragg 7 , Christopher E Brightling 8 , Stefano Aliberti 9
Affiliation  

SARS-CoV-2 is responsible for a multi-organ syndrome that can last over 12 months after the initial infection, which includes pulmonary and systemic consequences with residual radiological or functional alterations [1–3]. According to international guidelines, post-COVID-19 syndrome or condition is defined by a variety of signs and symptoms occurring during or after an infection consistent with COVID-19, lasting for more than 8–12 weeks and not explained by an alternative diagnosis [4, 5]. Main symptoms are fatigue, dyspnoea, arthralgia, chest pain, cough and neurocognitive impairment [6].



中文翻译:


欧洲各地的 COVID-19 后续计划:ERS END-COVID CRC 调查



SARS-CoV-2 会导致多器官综合征,这种综合征在初次感染后可持续 12 个月以上,其中包括肺部和全身后果以及残留的放射学或功能改变 [1-3]。根据国际指南,COVID-19 后综合症或病症是指在与 COVID-19 一致的感染期间或之后出现的各种体征和症状,持续超过 8-12 周,并且不能用其他诊断来解释。 4、5]。主要症状是疲劳、呼吸困难、关节痛、胸痛、咳嗽和神经认知障碍[6]。

更新日期:2022-09-15
down
wechat
bug